Nathaniel Posner is a Director of Health Economics and Outcomes Research at Pfizer, specializing in HYMPAVZI for Hemophilia A and B. Previously, they held various roles at Pfizer, including Senior Manager and Global Marketing lead. Nathaniel earned a Master's Degree in Health Policy & Management from Boston University School of Public Health and is currently pursuing a Master of Science in Quantitative Management: Health Analytics at Duke University. They also have experience as a Graduate Tutor and Research Assistant, having contributed to significant studies in health economics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices